Molekulárisan célzott biológiai terápia a szolid tumorok kezelésében - 1. Emlorák és colorectalis rák

Translated title of the contribution: Molecularly targeted biological therapy in the treatment of solid tumours part one - Breast cancer and colorectal cancer

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Modern biological oncotherapy of solid tumours means targeting various kinase inhibitor pathways either by specific monoclonal antibodies against extracellular receptors or ligands (trastuzumab, cetuximab, panitumumab, bevacizumab) or by small molecular weight oral kinase inhibitors that interfere with intracellular signal transduction (imatinib, sunitinib, lapatinib, erlotinib, gefitinib, sorafenib). Here we review the clinical use of targeted biological agents in breast and colorectal cancer.

Translated title of the contributionMolecularly targeted biological therapy in the treatment of solid tumours part one - Breast cancer and colorectal cancer
Original languageHungarian
Pages (from-to)565-570
Number of pages6
JournalLege Artis Medicinae
Volume17
Issue number8-9
Publication statusPublished - Sep 1 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Molecularly targeted biological therapy in the treatment of solid tumours part one - Breast cancer and colorectal cancer'. Together they form a unique fingerprint.

  • Cite this